Jay Hastings, CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company that offers genetic and blood testing and telehealth programs, including GLP-1 weight management. He has more than 20 years of experience across genomics, laboratory operations, healthcare innovation, healthcare investing and strategic finance, including building and scaling CLIA-certified laboratory businesses.
Jay is not a clinician. His name is on each article on the PlexusDx blog that ends with a section headed "How we made this page", and he is responsible for what those articles say.
Background
- PlexusDx: chief executive officer since February 2023.
- Base10 Genetics: chief executive officer since 2023. He led its acquisition and integration of a CLIA-licensed infectious disease laboratory.
- Seaport Diagnostics: director of finance, 2015 to 2018.
- Mass General Brigham: administrative roles in provider services, 2006 to 2015.
- Finance: investment, trading and wealth management roles at 3i Capital, J.P. Morgan and Morgan Stanley.
- Education: MS in finance from Northeastern University and BA in economics from the University of Massachusetts Amherst.
His full work history is on his LinkedIn profile: Jay Hastings on LinkedIn.
How the articles under his name are made
- Drafting. AI tools read the sources listed in the article and draft it from them.
- Checking. Automated checks and separate AI reviewers compare the draft with its sources and look for medical, legal, factual and reader problems. Jay confirms the statements about PlexusDx itself, such as its prices and terms.
- Approval. Jay reviews the final version and approves it before it is published, or sends it back for changes. The article's "How we made this page" section gives the date he approved it.
- Medical review. Medical content is reviewed by Dr. Asad K. Niazi, MD, MPH, not by Jay. Dr. Niazi is co-founder and CEO of Lone Star Virtual Health, the company that provides PlexusDx's clinicians, so he has a business relationship with PlexusDx. An article names Dr. Niazi only after he has reviewed that version.
Our editorial policy explains each step and the sources we use.
What Jay does not do
- He does not diagnose, treat or prescribe, and he does not give medical advice. An article is not advice about your own health, so talk with your own clinician before you start, stop or change a treatment.
- He is not the medical reviewer. That is Dr. Niazi's role.
His financial interest
PlexusDx sells compounded GLP-1 treatment, so we have a financial interest in the topics these articles cover. As CEO, Jay shares that interest. Articles that discuss treatments, prices or providers say so near the top and again at the end.
Report an error
If you think an article is wrong or out of date, our editorial policy explains how to report it and how we correct it.
This page was drafted with AI tools from Jay's biography and LinkedIn profile. Jay Hastings approved it on October 19, 2026.
